Friday 16 October 2026
Export TLSA’s income statement to Excel — free account
Tiziana Life Sciences Ltd
TLSA Healthcare Biotechnology
Insiders bought in the last twelve months.
1.06
0.01
+0.95%
Follow TLSA
| Older periods | Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.00% | 0.00% | 0.00% | 0.00% | |
| 0.00% | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(46.34) | (28.25) | (23.69) | (20.86) | |
Capital Expenditures |
(0.04) | (0.03) | (0.04) | (0.06) | |
| Other line items | |||||
Cash ROIC |
(1,552.46%) | (368.79%) | (143.98%) | (513.44%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
16.50 | 0.00 | 20.56 | 0.00 | |
Capex/Depreciation |
(0.14) | (0.10) | (0.11) | (0.12) | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates